Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Information for healthcare professionals: Rituximab
Estrogen treatment in multiple sclerosis.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Oligodendroglial membrane dynamics in relation to myelin biogenesis.
Glatiramer Acetate Guards Against Rapid Memory Decline During Relapsing-Remitting Experimental Autoimmune Encephalomyelitis.
The challenge of comorbidity in clinical trials for multiple sclerosis.
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Visualization of myelination in GFP-transgenic zebrafish.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Monoclonal antibodies in MS: mechanisms of action.
European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Drugs@FDA (Enter "glatiramer acetate" in search box.)
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.

Pages